We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

146 hedge funds and large institutions have $549M invested in Amphastar Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 53 increasing their positions, 44 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 17

20% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 44

15% more capital invested

Capital invested by funds: $476M → $549M (+$72.8M)

8% more funds holding

Funds holding: 135 → 146 (+11)

2.34% more ownership

Funds ownership: 54.89% → 57.23% (+2.3%)

Holders
146
Holders Change
+11
Holders Change %
+8.15%
% of All Funds
2.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
53
Reduced
44
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$10.5M
2
N
Nuveen
North Carolina
+$4.59M
3
Wells Fargo
Wells Fargo
California
+$3.5M
4
FCM
Frontier Capital Management
Massachusetts
+$3.49M
5
JP Morgan Chase
JP Morgan Chase
New York
+$2.58M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$2.74M
2
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D
New Jersey
-$2.34M
3
BlackRock
BlackRock
New York
-$2.03M
4
Millennium Management
Millennium Management
New York
-$1.94M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$1.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
6M
76
6 Meridian
Kansas
$420K -$5.77K -306 -1%
CSS
77
Cubist Systematic Strategies
Connecticut
$411K +$101K +5,357 +36%
New York State Teachers Retirement System (NYSTRS)
78
New York State Teachers Retirement System (NYSTRS)
New York
$410K -$1.88K -100 -0.5%
FP
79
Factorial Partners
New York
$403K +$377K +20,000 New
AQR Capital Management
80
AQR Capital Management
Connecticut
$401K -$87.7K -4,653 -19%
Victory Capital Management
81
Victory Capital Management
Texas
$395K +$6.16K +327 +2%
ProShare Advisors
82
ProShare Advisors
Maryland
$386K +$33.3K +1,768 +10%
AB
83
Amalgamated Bank
New York
$363K +$339K +18,011 New
Two Sigma Advisers
84
Two Sigma Advisers
New York
$351K -$399K -21,200 -55%
EGM
85
Engineers Gate Manager
New York
$346K -$93.9K -4,986 -22%
Millennium Management
86
Millennium Management
New York
$333K -$1.94M -103,185 -86%
LSERS
87
Louisiana State Employees Retirement System
Louisiana
$333K -$1.88K -100 -0.6%
GC
88
Globeflex Capital
California
$332K +$310K +16,457 New
Bank of Montreal
89
Bank of Montreal
Ontario, Canada
$331K +$81K +4,299 +37%
QI
90
QS Investors
New York
$321K – – –
OPERF
91
Oregon Public Employees Retirement Fund
Oregon
$300K – – –
DekaBank Deutsche Girozentrale
92
DekaBank Deutsche Girozentrale
Germany
$299K – – –
OQS
93
Occudo Quantitative Strategies
Florida
$280K +$262K +13,910 New
Public Employees Retirement Association of Colorado
94
Public Employees Retirement Association of Colorado
Colorado
$277K – – –
State of Tennessee, Department of Treasury
95
State of Tennessee, Department of Treasury
Tennessee
$263K – – –
MLICM
96
Metropolitan Life Insurance Company (MetLife)
New York
$253K +$22.1K +1,172 +10%
RHBC
97
R.H. Bluestein & Co
Michigan
$252K – – –
AIM
98
Aigen Investment Management
New York
$250K -$69.5K -3,687 -23%
FTDI
99
First Trust Direct Indexing
Massachusetts
$241K +$678 +36 +0.3%
MIM
100
MetLife Investment Management
New Jersey
$238K – – –
2 3
4
5 6

AMPH Hedge Fund Activity: Q2 2021 in Review

146 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q2 2021, worth a combined $549M — up 15% from $476M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new AMPH positions and 17 closed out — a net gain of 11 holders — while 53 added to existing stakes and 44 trimmed.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $10.5M. The largest seller was Invesco, cutting an estimated $2.74M.

  • 146 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q2 2021, up from 135 in Q1 2021.
  • Funds reported $549M of Amphastar Pharmaceuticals stock for Q2 2021, up 15% quarter-over-quarter.
  • 28 funds opened new Amphastar Pharmaceuticals positions in Q2 2021 and 17 closed out, a net change of +11 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q2 2021 was Janus Henderson Group, an estimated $10.5M added.
  • The largest Amphastar Pharmaceuticals seller in Q2 2021 was Invesco, an estimated $2.74M sold.

Based on aggregated 13F filings for Q2 2021.